Teleflex Incorporated (NYSE:TFX) Receives Average Recommendation of “Hold” from Brokerages

Shares of Teleflex Incorporated (NYSE:TFX) have received an average recommendation of “Hold” from the twelve research firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, six have given a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $151.80.

Several research analysts have recently weighed in on the stock. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a report on Wednesday, June 24th. Raymond James Financial restated an “outperform” rating and issued a $150.00 target price on shares of Teleflex in a report on Friday, May 8th. Piper Sandler reaffirmed an “overweight” rating and issued a $169.00 target price (up from $160.00) on shares of Teleflex in a research report on Friday, August 7th. UBS Group boosted their target price on shares of Teleflex from $145.00 to $158.00 and gave the company a “neutral” rating in a research note on Tuesday, August 11th. Finally, Needham & Company LLC increased their price target on Teleflex from $147.00 to $159.00 and gave the company a “buy” rating in a report on Friday, July 31st.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of TFX. Waterfront Wealth Inc. purchased a new stake in shares of Teleflex during the 4th quarter valued at about $2,050,000. Ruffer LLP purchased a new position in shares of Teleflex in the fourth quarter worth approximately $5,154,000. Eos Management L.P. purchased a new position in shares of Teleflex in the fourth quarter worth approximately $3,763,000. Universal Beteiligungs und Servicegesellschaft mbH grew its position in Teleflex by 227.5% during the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 27,822 shares of the medical technology company’s stock valued at $3,395,000 after buying an additional 19,327 shares during the period. Finally, First Eagle Investment Management LLC increased its holdings in Teleflex by 163.4% during the fourth quarter. First Eagle Investment Management LLC now owns 84,300 shares of the medical technology company’s stock valued at $10,288,000 after buying an additional 52,300 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

NYSE TFX opened at $138.99 on Monday. Teleflex has a one year low of $100.18 and a one year high of $145.00. The stock has a 50-day moving average of $132.70 and a 200 day moving average of $124.73. The company has a market capitalization of $5.89 billion, a price-to-earnings ratio of -5.97, a PEG ratio of 0.90 and a beta of 0.81. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.12 and a current ratio of 2.60.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.48. The business had revenue of $570.33 million during the quarter, compared to analyst estimates of $559.59 million. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.Teleflex’s revenue was up 28.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, sell-side analysts forecast that Teleflex will post 7.26 EPS for the current year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, August 14th will be issued a $0.34 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s payout ratio is presently -5.84%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.